<?xml version="1.0" encoding="UTF-8"?>
<p>Another type of non-ionic synthetic surfactant [formed by the esterification of Vitamin E in a reaction catalyzed by polyethylene glycol (PEG) 100], is D-Î±-Tocopheryl polyethylene glycol 1000 succinate (TPGS/Vitamin E TPGS), a water-soluble derivative of natural Vitamin E [
 <xref rid="B87-pharmaceutics-12-00688" ref-type="bibr">87</xref>,
 <xref rid="B88-pharmaceutics-12-00688" ref-type="bibr">88</xref>]. Being readily miscible with oils as well as an important solubilizer of water-soluble and -insoluble agents, TPGS surfactants have been extensively used in drug delivery systems (DDSs) [
 <xref rid="B89-pharmaceutics-12-00688" ref-type="bibr">89</xref>]. Specifically, it has been reported that TPGS surfactants possess a variety of functions as (i) the enhancers of drug solubility [
 <xref rid="B90-pharmaceutics-12-00688" ref-type="bibr">90</xref>], (ii) the excipients for multidrug resistance (MDR) and drug absorption [
 <xref rid="B91-pharmaceutics-12-00688" ref-type="bibr">91</xref>], (iii) the enhancers of drug cytotoxicity [
 <xref rid="B92-pharmaceutics-12-00688" ref-type="bibr">92</xref>] and (iv) anti-tumor agents synergistically acting with other anticancer drugs [
 <xref rid="B93-pharmaceutics-12-00688" ref-type="bibr">93</xref>]. Furthermore, these molecules were able to prevent the cyclosporin A (CsA, an immunosuppressive drug)-induced production of ROS and inhibit the loss of protein-bound sulfhydryl groups [
 <xref rid="B94-pharmaceutics-12-00688" ref-type="bibr">94</xref>]. 
</p>
